• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

比较仅基于临床因素和临床与实验室指标相结合的模型对难治性心脏骤停患者实施体外心肺复苏术(ECPR)的预后情况。

Comparing clinical only and combined clinical laboratory models for ECPR outcomes in refractory cardiac arrest.

作者信息

Chiu Chun-Chieh, Chang Yu-Jun, Chiu Chun-Wen, Chen Ying-Chen, Hsieh Yung-Kun, Hsiao Shun-Wen, Yen Hsu-Heng, Siao Fu-Yuan

机构信息

Department Emergency and Critical Care Medicine, Changhua Christian Hospital, Changhua, 50006, Taiwan.

Epidemiology and Biostatics Center, Changhua Christian Hospital, Changhua, 50006, Taiwan.

出版信息

Sci Rep. 2025 Jan 23;15(1):2915. doi: 10.1038/s41598-025-87200-7.

DOI:10.1038/s41598-025-87200-7
PMID:39849010
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11757996/
Abstract

Extracorporeal cardiopulmonary resuscitation (ECPR) improves survival for prolonged cardiac arrest (CA) but carries significant risks and costs due to ECMO. Previous predictive models have been complex, incorporating both clinical data and parameters obtained after CPR or ECMO initiation. This study aims to compare a simpler clinical-only model with a model that includes both clinical and pre-ECMO laboratory parameters, to refine patient selection and improve ECPR outcomes. Medical records between January 2012 and January 2019 in our institution were retrospectively reviewed. Patients who met the following criteria were enrolled in the ECPR program: age 18-75 years, CCPR started with CA in < 5 min, CA was assumed to be of heart origin, and refractory CA. Survivors had similar underlying diseases and younger age without statistical significance (57.0 vs. 61.0 years, p = 0.117). Survivors had significantly higher rates of initial shockable rhythm, pulseless ventricular tachycardia and ventricular fibrillation, shorter low-flow time (CPR-to-ECMO time), lower lactate levels, and higher initial pH. Survival to discharge was higher for emergency department CA than for out-of-hospital and in-hospital CA (63.3% vs. 35.3%, p = 0.007). Two models were used for evaluating survival to discharge and good neurological outcomes. Model 1, short version based on clinical factors, (S1, survival score 1; F1, function score 1) included the patient's characteristics before ECPR, whereas Model 2, full version included clinical factors and laboratory data including lactate and pH levels (S2, survival score 2; F2, function score 2). Both Model 1(S1) and Model 2(S2) showed good predictive ability for survival to discharge with areas under the receiver operating characteristic (AUROCs) of 0.79 and 0.83, respectively. Model 1(F1) and Model 2(F2) revealed prediction power for good neurological outcomes, with AUROCs of 0.80 and 0.79, respectively. The AUROCs of survival score Model 1(S1) and 2(S2) and function score Model 1(F1) and 2(F2) were not significantly different. This study demonstrates that clinical factors alone can effectively predict survival to discharge and favorable neurological outcomes at 6 months. This emphasizes the importance of early prognostic evaluation and supports the use of clinical data as a practical tool for clinicians in decision-making for this difficult situation.

摘要

体外心肺复苏(ECPR)可提高长时间心脏骤停(CA)患者的生存率,但由于使用体外膜肺氧合(ECMO),存在重大风险和成本。以往的预测模型较为复杂,纳入了临床数据以及心肺复苏(CPR)或启动ECMO后获得的参数。本研究旨在比较一个更简单的仅基于临床因素的模型与一个包含临床和ECMO前实验室参数的模型,以优化患者选择并改善ECPR的治疗效果。我们对本机构2012年1月至2019年1月期间的病历进行了回顾性研究。符合以下标准的患者纳入ECPR项目:年龄18 - 75岁,心脏骤停发生后5分钟内开始进行持续胸外按压(CCPR),假定心脏骤停源于心脏,且为难治性心脏骤停。幸存者的基础疾病相似,年龄更小,但无统计学意义(57.0岁对61.0岁,p = 0.117)。幸存者初始可电击心律、无脉性室性心动过速和室颤的发生率显著更高,低流量时间(CPR至ECMO时间)更短,乳酸水平更低,初始pH值更高。急诊科心脏骤停患者出院生存率高于院外和院内心脏骤停患者(63.3%对35.3%,p = 0.007)。使用两个模型评估出院生存率和良好的神经功能转归。模型1为基于临床因素的简化版(S1,生存评分1;F1,功能评分1),包括ECPR前患者的特征,而模型2为完整版,包括临床因素和实验室数据,如乳酸水平和pH值(S2,生存评分2;F2,功能评分2)。模型1(S1)和模型2(S2)对出院生存率均显示出良好的预测能力,受试者工作特征曲线下面积(AUROCs)分别为0.79和0.83。模型1(F1)和模型2(F2)对良好的神经功能转归显示出预测能力,AUROCs分别为0.80和0.79。生存评分模型1(S1)和2(S2)以及功能评分模型1(F1)和2(F2)的AUROCs无显著差异。本研究表明,仅临床因素就能有效预测出院生存率和6个月时良好的神经功能转归。这强调了早期预后评估的重要性,并支持临床医生将临床数据作为在这种困难情况下进行决策的实用工具。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/264f/11757996/5f2975e41059/41598_2025_87200_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/264f/11757996/8ebb0e3ecc2d/41598_2025_87200_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/264f/11757996/385dd2a9b7a8/41598_2025_87200_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/264f/11757996/ddcbd0606f03/41598_2025_87200_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/264f/11757996/5f2975e41059/41598_2025_87200_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/264f/11757996/8ebb0e3ecc2d/41598_2025_87200_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/264f/11757996/385dd2a9b7a8/41598_2025_87200_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/264f/11757996/ddcbd0606f03/41598_2025_87200_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/264f/11757996/5f2975e41059/41598_2025_87200_Fig4_HTML.jpg

相似文献

1
Comparing clinical only and combined clinical laboratory models for ECPR outcomes in refractory cardiac arrest.比较仅基于临床因素和临床与实验室指标相结合的模型对难治性心脏骤停患者实施体外心肺复苏术(ECPR)的预后情况。
Sci Rep. 2025 Jan 23;15(1):2915. doi: 10.1038/s41598-025-87200-7.
2
Neurological outcomes and duration from cardiac arrest to the initiation of extracorporeal membrane oxygenation in patients with out-of-hospital cardiac arrest: a retrospective study.院外心脏骤停患者体外膜肺氧合启动与心脏骤停至开始之间的神经系统结局和持续时间:一项回顾性研究。
Scand J Trauma Resusc Emerg Med. 2017 Sep 16;25(1):95. doi: 10.1186/s13049-017-0440-7.
3
Managing cardiac arrest with refractory ventricular fibrillation in the emergency department: Conventional cardiopulmonary resuscitation versus extracorporeal cardiopulmonary resuscitation.急诊科难治性心室颤动致心脏骤停的处理:常规心肺复苏与体外心肺复苏。
Resuscitation. 2015 Jul;92:70-6. doi: 10.1016/j.resuscitation.2015.04.016. Epub 2015 Apr 29.
4
Extracorporeal cardiopulmonary resuscitation for refractory cardiac arrest: A multicentre experience.体外心肺复苏用于难治性心脏骤停:一项多中心经验
Int J Cardiol. 2017 Mar 15;231:131-136. doi: 10.1016/j.ijcard.2016.12.003. Epub 2016 Dec 6.
5
An optimal transition time to extracorporeal cardiopulmonary resuscitation for predicting good neurological outcome in patients with out-of-hospital cardiac arrest: a propensity-matched study.预测院外心脏骤停患者良好神经功能预后的体外心肺复苏最佳转换时间:一项倾向匹配研究。
Crit Care. 2014 Sep 26;18(5):535. doi: 10.1186/s13054-014-0535-8.
6
Extracorporeal Membrane Oxygenation for Cardiac Indications in Adults: A Health Technology Assessment.成人心脏适应症的体外膜肺氧合:一项卫生技术评估
Ont Health Technol Assess Ser. 2020 Mar 6;20(8):1-121. eCollection 2020.
7
Comparison of extracorporeal and conventional cardiopulmonary resuscitation: a retrospective propensity score matched study.体外心肺复苏与常规心肺复苏的比较:一项回顾性倾向评分匹配研究。
Crit Care. 2019 Jan 28;23(1):27. doi: 10.1186/s13054-019-2320-1.
8
Predictors of Survival for Nonhighly Selected Patients Undergoing Resuscitation With Extracorporeal Membrane Oxygenation After Cardiac Arrest.心脏骤停后行体外膜肺氧合复苏的非高危患者的生存预测因素。
ASAIO J. 2018 May/Jun;64(3):368-374. doi: 10.1097/MAT.0000000000000644.
9
Long-term health-related quality of life in survivors of extracorporeal cardiopulmonary resuscitation compared to conventional cardiopulmonary resuscitation- A cohort study using Australian and New Zealand extracorporeal membrane oxygenation registry and the Victorian Ambulance Cardiac Arrest Registry.与传统心肺复苏相比,体外心肺复苏幸存者的长期健康相关生活质量——一项使用澳大利亚和新西兰体外膜肺氧合登记处以及维多利亚州救护车心脏骤停登记处的队列研究。
Resuscitation. 2025 May;210:110601. doi: 10.1016/j.resuscitation.2025.110601. Epub 2025 Apr 3.
10
Extracorporeal cardiopulmonary resuscitation for refractory in-hospital cardiac arrest: A retrospective cohort study.体外心肺复苏治疗难治性院内心脏骤停:一项回顾性队列研究。
Int J Cardiol. 2022 Mar 1;350:48-54. doi: 10.1016/j.ijcard.2021.12.053. Epub 2022 Jan 5.

本文引用的文献

1
Extracorporeal cardiopulmonary resuscitation outcomes for children with out-of-hospital and emergency department cardiac arrest.体外心肺复苏术治疗院外和急诊科心脏骤停儿童的结果。
Am J Emerg Med. 2024 Jul;81:35-39. doi: 10.1016/j.ajem.2024.03.035. Epub 2024 Apr 7.
2
2023 American Heart Association Focused Update on Adult Advanced Cardiovascular Life Support: An Update to the American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care.2023 年美国心脏协会成人高级心血管生命支持重点更新:对美国心脏协会心肺复苏和紧急心血管护理指南的更新。
Circulation. 2024 Jan 30;149(5):e254-e273. doi: 10.1161/CIR.0000000000001194. Epub 2023 Dec 18.
3
Prognostic models for mortality risk in patients requiring ECMO.
需要 ECMO 支持的患者死亡率风险预测模型。
Intensive Care Med. 2023 Feb;49(2):131-141. doi: 10.1007/s00134-022-06947-z. Epub 2023 Jan 4.
4
Resuscitation Using ECPR During In-Hospital Cardiac Arrest (RESCUE-IHCA) Mortality Prediction Score and External Validation.应用体外心肺复苏(ECPR)于院内心脏骤停患者的复苏(RESCUE-IHCA)死亡率预测评分及其外部验证。
JACC Cardiovasc Interv. 2022 Feb 14;15(3):237-247. doi: 10.1016/j.jcin.2021.09.032. Epub 2022 Jan 12.
5
Extracorporeal cardiopulmonary resuscitation in adults: evidence and implications.成人体外心肺复苏术:证据与影响。
Intensive Care Med. 2022 Jan;48(1):1-15. doi: 10.1007/s00134-021-06514-y. Epub 2021 Sep 10.
6
A systematic review of current ECPR protocols. A step towards standardisation.当前体外心肺复苏(ECPR)方案的系统评价。迈向标准化的一步。
Resusc Plus. 2020 Jul 19;3:100018. doi: 10.1016/j.resplu.2020.100018. eCollection 2020 Sep.
7
Survival and Outcomes After Cardiac Arrest With VA-ECMO Rescue Therapy.采用VA-ECMO挽救治疗的心脏骤停后的生存情况及预后
Shock. 2021 Dec 1;56(6):939-947. doi: 10.1097/SHK.0000000000001809.
8
Survival on Venoarterial Extracorporeal Membrane Oxygenation in Cardiogenic Shock: Which Lactate Is Most Useful?心源性休克患者行体外膜肺氧合治疗的生存预后:哪种乳酸最有用?
ASAIO J. 2022 Jan 1;68(1):41-45. doi: 10.1097/MAT.0000000000001413.
9
Development and Validation of a Clinical Score to Predict Neurological Outcomes in Patients With Out-of-Hospital Cardiac Arrest Treated With Extracorporeal Cardiopulmonary Resuscitation.《应用体外心肺复苏治疗院外心脏骤停患者的临床评分对预测其神经系统结局的开发与验证》
JAMA Netw Open. 2020 Nov 2;3(11):e2022920. doi: 10.1001/jamanetworkopen.2020.22920.
10
Advanced reperfusion strategies for patients with out-of-hospital cardiac arrest and refractory ventricular fibrillation (ARREST): a phase 2, single centre, open-label, randomised controlled trial.针对院外心脏骤停和难治性心室颤动患者的高级再灌注策略(ARREST):一项 2 期、单中心、开放标签、随机对照试验。
Lancet. 2020 Dec 5;396(10265):1807-1816. doi: 10.1016/S0140-6736(20)32338-2. Epub 2020 Nov 13.